Condition
NSAID (Non-Steroidal Anti-Inflammatory Drug)
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 4 (2)
Trial Status
Recruiting2
Enrolling By Invitation1
Active Not Recruiting1
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07533266Phase 4Not Yet RecruitingPrimary
Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
NCT07493226Not ApplicableRecruiting
Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis
NCT07178639Not ApplicableRecruiting
Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery
NCT06834425Not ApplicableActive Not Recruiting
Efficacy of NSAID Peritendinous Injection for Acute Tendinitis
NCT06484192Phase 4Enrolling By Invitation
Pain Control After Lumbar Spine Fusion
Showing all 5 trials